Visual Impairment, Oscillopsia and Multiple Sclerosis

Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Terminated
CT.gov ID
NCT00498199
Collaborator
(none)
100
1

Study Details

Study Description

Brief Summary

This study consists of two parts. The first part is a survey to examine vision-specific health-related quality of life in a cohort of patients with multiple sclerosis. We test visual impairment like visual acuity, visual field, colour discrimination, contrast sensitivity, eye movement. The aim of this part is to examine the association between responses to the quality of life scale and objective measures of visual impairment.

The second part is an open controlled study, in which we measure motion detection threshold in MS patients with oscillopsia due to pendular nystagmus and in a group of control subjects. The objective of this part is to determine whether patients with pendular nystagmus develop adaptation to oscillopsia using increased threshold of motion detection. We plan to test the effect of visuo-motor rehabilitation on this threshold in patients with oscillopsia due to pendular nystagmus.

Condition or Disease Intervention/Treatment Phase
  • Procedure: visual tests

Detailed Description

In the first part, 100 patients with multiple sclerosis are included. A vision-specific health-related quality of life scale and neuro-ophthalmological tests are administered. The duration of intervention is about 3 hours by patient and one year to finish this part.

In the second part, we include about 40 of 100 MS patients who present an oscillopsia due to pendular nystagmus and a group of 20 control subjects. The patients and subject will perform a motion detection task and the vision-specific health-related quality of life, the intervention lasting 1 hour. Then the patients will be randomized in one group treated by rehabilitation (one 30 mn session per week during 3 months) and the other one without treatment. A motion detection task and the vision-specific health-related quality of life scale will be performed at the end of the treatment for both groups.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Visual Impairment, Oscillopsia and Multiple Sclerosis
Study Start Date :
Apr 1, 2007

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age 18 to 90

    • Patients with established multiple sclerosis

    • Visual impairment recovering from MS

    • Understanding rules task

    • Patient can stay set a long time

    • Patient's agreement

    • Membership to the Social Security

    • No relapsing since three months

    Exclusion Criteria:
    • Brain damage

    • Cognitive or behaviour disorder

    • Patients with peripheral vestibular, otologic or ophthalmologic pathology antecedent

    • Not stabilized disease (other one than MS)

    • Patient under guardianship

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Caroline Tilikete Lyon France 69677

    Sponsors and Collaborators

    • Hospices Civils de Lyon

    Investigators

    • Principal Investigator: Caroline Tilikete, MD, Hospices Civils de Lyon

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00498199
    Other Study ID Numbers:
    • 2006.432
    First Posted:
    Jul 9, 2007
    Last Update Posted:
    Sep 30, 2010
    Last Verified:
    Jul 1, 2007

    Study Results

    No Results Posted as of Sep 30, 2010